The stock chart for Takedown Entertainment, Inc. (OTCBB: TKDN) is holding a base at 2 cents and pushed through a resistance point at $0.022 with a slight increase in volume on Tuesday. The indicators have been trending towards bullish positions over the last month; giving hints of a potential rise in price and reversal of the downward trend. The candles Read More

Mustang Alliances (OTCBB:MSTG) has been in a strong uptrend for several months. After a consolidation, the price per share has held the 50dma and is back on the climb looking to challenge the old highs at $1.48. Read More

We are re-visiting the Sino Payments, Inc. (OTCQB:SNPY) after a sharp make a new 52-week high, the SNPY chart has consolidated and is starting to climb again. Charts must retrace to reset indicators and SNPY has done that and now looks positioned to challenge the highs again. Volume is increasing Read More

The ADVENTRX Pharmaceuticals Inc. (AMEX:ANX) stock chart is holding a solid support level at $0.56 and climbing again towards the upper portion of a multi-month channel with resistance at 67 cents. Volume has remained consistent, but technical traders will be looking for a surge to take out the top of the channel with the next resistance not until 81 cents. On a pullback, the bottom support must hold for the stock chart to remain in play. Read More

The Brekford Corp. (OTCBB: BFDI) stock chart has been in a solid uptrend for nearly a year.  After a brief consolidation which dipped the price to support, a push at the end of 2011 has the chart kicking-off the new year at resistance and looking for a blue sky breakout passed 70 cents. Read More

The stock chart for Li-ion Motors Corporation (OTCBB: LMCO) made a sharp climb off bottom support at a nickel to move to 15 cents over the last couple weeks. A mild retrace happened and now another push could be in the making. Shares closed at 16 cents yesterday as the indicators are holding bullish Read More

A strong chart climbing from a penny to 9 cents over the last year, Business Continuity Solutions, Inc. (Pink Sheets: BUCS) is holding the majority of the gains in the area of 7 cents presently.  A solid support is set at Read More

On a solid uptrend for nearly a month, shares of Opko Health, Inc. (AMEX:OPK) have risen from $3.50 to now face resistance in the area of $4.50. Volume has been increasing the last two days and the stock will be facing a true test now as there is no resistance in the way if $4.50 can be broken until testing old highs around $5.00.

Opko has recently announced that it has been awarded a $200,000 research grant from the University of Pennsylvania Center for Orphan Disease Research and Therapy to develop a therapeutic agent to treat Mucopolysaccharidoses Type I (MPS I). A recent article on Seeking Alpha reported that the CEO of Opko has been making regular purchases of the common stock of OPK.

Opko Health (OPK) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Taking on a double bottom look at this point, the GNMT stock chart has support at $0.028 and $0.025 with resistance set at 3 cents. The MACD has a nice trend back towards zero underway and the RSI is giving a neutral reading, but appears to be trying to push. Technical traders will be closely watching the support and for volume to give the pps a lift towards resistance this week.

General Metals Corp. (GNMT) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

With a bottom support at $0.018 and a stronger price per share support at $0.02, the POSC chart has made a double bottom and appears to be trying to move upward off the bottom again. Big swings have been part of the trading pattern of POSC which will have technical traders on alert for another surge in momentum.

Positron Corp. (POSC) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.